investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Genomic Characteristics of VRE Bloodstream Infection in Patients with Hematological Malignancies: Impact on Clinical Outcomes in Six Geographical Regions
Javier Adachi
7 Collaborator(s)
Funding source
University of Texas MD Anderson Cancer Center
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Keiichi Furukawa
St. Luke's International University
Tokyo, Japan
Jose Munita
Clínica Alemana
Santiago, Chile
George Weinstock
Jackson Laboratory
Bar Harbor, United States
Cesar Arias
University of Texas Health Science Center at Houston
Houston, United States
Aline El Zakhem
American University of Beirut
Beirut, Lebanon
Nelson Hamerschlak
Albert Einstein Hospital
São Paulo, Brazil
Javier Adachi
University of Texas MD Anderson Cancer Center
Houston, United States
Carlos Vallejos
Instituto Nacional de Enfermedades Neoplásicas
Lima, Peru
Oncosalud-AUNA
Lima, Peru
Related projects
Clark W Distelhorst
Bcl-2 Function on the Endoplasmic Reticulum
Leukaemia
Hematology and hematologic malignancies
Andrew G Myers
Synthesis and Study of Natural and Non-natural Antiproliferative Agents
Leukaemia
Hematology and hematologic malignancies
David A Fruman
TOR Kinase Inhibitors for Leukemia Therapy: Mechanisms of Action and Resistance
Leukaemia
Hematology and hematologic malignancies
Thomas J Kipps
Chronic Lymphocytic Leukemia Research Consortium
Leukaemia
Hematology and hematologic malignancies
Richard Aplenc
Genetic Predictors of AML Treatment Response
Leukaemia
Hematology and hematologic malignancies
Richard Aplenc
Toxicity Monitoring on Phase III Trials with Administrative Data
Leukaemia
Hematology and hematologic malignancies
Roland B Walter
Prediction of Treatment-Related Mortality and Therapeutic Resistance in AML
Leukaemia
Hematology and hematologic malignancies
Daniel G Tenen
Molecular biology of myeloid differentiation
Leukaemia
Hematology and hematologic malignancies
Jeffrey S Miller
NK Cells, their Receptors and Unrelated Donor Transplant
Leukaemia
Hematology and hematologic malignancies
